The Noneffect Of Myriad On Personalized Medicine

Law360, New York (July 29, 2013, 12:08 PM EDT) -- One purpose of the legal system is to incentivize behaviors that are deemed good public policy. While it is not controversial that patent laws should not allow companies to own rights to our bodies, whether and to what extent patent law should provide incentives to research and develop products, including in the area of personalized medicine, has been the subject of debate.

The ability to personalize treatment, for example, by identifying patients at risk for particular diseases and by identifying those patients who will respond well...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.